Fibronostics

Advancing liver care starts with meaningful clinical conversations.

Recently, Fibronostics hosted a LIVERFASt™ Dinner & Learn in Coral Gables, Florida, bringing together healthcare professionals from gastroenterology, infectious disease, care coordination, laboratory management, and clinical practice leadership.

Led by Dr. Mona Munteanu, Chief Scientific Officer of Fibronostics and lead scientist behind LIVERFASt™, the session focused on the evolving landscape of metabolic liver disease and the growing need for accessible, non-invasive approaches to liver disease assessment.

The evening provided an opportunity to discuss real-world clinical challenges, explore current evidence, and exchange perspectives on how innovative testing solutions can support earlier identification and management of patients with MASLD and MASH.

Maria Torbica, our Fibronostics representative in Florida, whose efforts in bringing together healthcare providers from across the region, helped make the event a success and foster meaningful clinical dialogue within the local medical community.

We are grateful to everyone who joined us and contributed to the discussion. Thank you to Dr. Mona for sharing her expertise and helping advance awareness of metabolic liver disease among healthcare professionals.

At Fibronostics, we remain committed to supporting clinicians through science, education, and evidence-based innovation.